U.S., April 24 -- ClinicalTrials.gov registry received information related to the study (NCT06940232) titled 'Validating a Blood Test for the Detection of Traumatic Brain Injury in Children' on April 14.
Brief Summary: The primary objective of this study is to establish if Glial Fibrillary Acidic Protein (GFAP) and Ubiquitin C-terminal Hydrolase L1 (UCH-L1) are predictive of computed tomography (CT) findings in pediatric traumatic brain injuries (TBI). The participant population is pediatric patients, ages 0 to less than 18 years old with a possible TBI or trauma-related injury who have blood drawn per standard of care in the emergency department. Blood samples will be analyzed using the i-STAT TBI cartridge (Abbott Laboratories, Abbott Pa...